11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management...(remendous value to the Company itsshareh...),Health

Date:12/4/2008

remendous value to the Company, its shareholders, and its physicians and employees by providing us Board representation and reappointing us to executive management positions in the Company. We have no doubt we can help provide the strategic vision the Company needs today, and have the experience and expertise to execute that strategy. We also believe that with these changes, the Board can fulfill its fiduciary duties to its shareholders by helping return some, if not all, of the shareholder value that has been so dramatically squandered over the last couple of years.

We have the unique experience and know-how to help get the Company back on track.

As large shareholders with deep roots to the Company, we also have the passion and commitment to make it happen. Given the current cash burn at the Company, we would appreciate a timely response to our requests made in this letter.

    Sincerely,

    Stephen N. Joffe
    Craig P.R. Joffe
    Alan Buckey

    cc: LCA-Vision Inc. Board of Directors

William Bahl, LCAV's Chairman of Compensation Committee; Director of Cincinnati Financial Corporation

John Gutfreund, LCAV's Chairman of Nominating & Governance Committee; Director of GVI Securities Solutions

    John Hassan, Independent Director, Chairman of Audit Committee


    For Further Information:
    Lisa Blaker
    9560 Montgomery Road
    Cincinnati, Ohio 45242
    (513) 659 2001

'/>"/>

SOURCE Steve Joffe Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
2. Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract
3. Senator Norm Coleman Praised for Leading Successful Effort to Derail $11.4 Million Minnesota Medicare Cuts
4. NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
5. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
6. Barr Shareholders Approve Pending Teva Acquisition
7. Cord Blood America Posts Letter to Shareholders: New Administrations Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders
8. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
9. MaxLife Fund Corp. declares dividends to shareholders of Preferred Shares
10. Westaim terminates reorganization agreement and cancels shareholders meeting
11. GeneThera - CHANGING DIRECTIONS - an Update to Shareholders